Analysts Say ‘Buy the Pullback’ in These 3 Stocks

Analysts Say ‘Buy the Pullback’ in These 3 Stocks

Oops!Something went wrong.Please try again later.Oops!Something went wrong.Please try again later.TipRanksApril 23, 2021, 8:39 AM·8 min readOops!Something went wrong.Please try again later.Oops!Something went wrong.Please try again later.Stock traders are known for their occasional love of aphorisms, and several come readily to mind. ‘Buy low, sell high' and ‘don't try to time the market' are two that have stood the test of time, and while they may sound contradictory, that's not necessarily the case. It's possible to buy low even in an upward trend.Checking in with Wall Street's analysts, to find out if the fundamentals are sound, can give some indications if a stock's pullback is just a temporary event. The analysts make their reputations by finding these opportunities, and bringing them to our attention.With this mind, we've used the TipRanks database to search for three stocks that have seen such recent pullbacks – and that show plenty of upside potential ahead, according to the analysts. Let's take a look at the details.Cardiff Oncology (CRDF)The first stock we're looking at, Cardiff Oncology, is a clinical stage biopharma company with a laser-focus on cancer treatment. Specifically, the company focuses on the development of medication options for cancer patients whose current treatment has